Skip to primary content
Skip to secondary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Tag Archives: EpiPen

Another Day, Another Exorbitant Drug Increase for a Vital Drug: Epipen

Posted on August 29, 2016 by gutsandgrowth

From NBC News: EpiPen Prices Rocket Along With Drugmaker Executive’s Pay

Screen Shot 2016-08-23 at 5.52.10 PM

Screen Shot 2016-08-23 at 5.52.37 PM

Screen Shot 2016-08-23 at 5.52.59 PM

Screen Shot 2016-08-23 at 5.53.55 PM

Also, this story has been discussed in NY Times (Epipen & Health Care System Dysfucntion) and USA Today (see below)

Screen Shot 2016-08-23 at 6.00.32 PM

 

Also, from KT Park’s twitter feed:

Screen Shot 2016-08-25 at 8.09.41 PM

Posted in General Health | Tagged drug prices, EpiPen

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Top Posts & Pages

  • In the News: FDA Approves 2nd Oral GLP-1, Another Vaccine Reduces Risk of Dementia, and Costs of Vaccine-Preventable Diseases
  • 75% of U.S. Adults Have Obesity When Using New Definition With Anthropometrics
  • Choosing Advanced Therapy for Crohn's Disease Based on Disease Location
  • Position Paper: Expediting Drug Approval for Pediatric IBD
  • GI Bleeding -Forrest Classification
  • Reduced Dosing of GLP-1 RAs May Work for Maintenance Treatment of Obesity
  • Flu Shots & Other Vaccines Linked to Lower Rates of Dementia
  • Oral GLP-1 Receptor Agonist for Obesity: Orforglipron
  • Shingles Vaccine Linked to Lower Dementia Risk
  • Comprehensive ACG Clinical Guidelines for Ulcerative Coliits (2025)

Log-In

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Recent Posts

  • Choosing Advanced Therapy for Crohn’s Disease Based on Disease Location
  • In the News: FDA Approves 2nd Oral GLP-1, Another Vaccine Reduces Risk of Dementia, and Costs of Vaccine-Preventable Diseases
  • Position Paper: Expediting Drug Approval for Pediatric IBD
  • Upadacitinib for Pediatric Ulcerative Colitis
  • Food for Thought: Studies of Food Intake and IBS and DGBI
  • Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists For Inflammatory Bowel Disease Patients
  • “Real-World” Experience: High Dose Upadacitinib Recaptures IBD Response
Blog at WordPress.com.
  • Subscribe Subscribed
    • gutsandgrowth
    • Join 945 other subscribers
    • Already have a WordPress.com account? Log in now.
    • gutsandgrowth
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar
 

Loading Comments...